Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huayu Qiangshen Tongbi Youhua C Fang (化瘀强肾通痹优化C方) is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of diabetic kidney disease (DKD), specifically targeting patients in the G3aA2 and G3aA3 stages. Developed by researchers at Longhua Hospital affiliated with the Shanghai University of Traditional Chinese Medicine, the formula is based on the therapeutic principles of tonifying the kidney, resolving blood stasis, and unblocking the collaterals to relieve 'Bi' syndrome (obstruction). It is designed to reduce proteinuria, stabilize the glomerular filtration rate (eGFR), and delay the progression of chronic renal failure. The formula typically consists of a refined combination of botanical extracts, including herbs such as Astragalus membranaceus and Salvia miltiorrhiza, which have been shown to exert nephroprotective effects by inhibiting renal fibrosis and inflammatory responses. This 'Optimized C' version is part of a series of formulas refined through multicenter clinical trials supported by the National Key Research and Development Program of China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 化瘀强肾通痹优化C方.